How Computational Biology is Transforming Drug R&D
The latest episode of Exchanges at Goldman Sachs premieres a new monthly feature: An examination of a topic at the center of conversations in the venture-capital community. This week, Goldman Sachs Research’s Heath Terry explores the growing world of computational biology—using the power of big dat…
Lux Capital's Zavain Dar on Investing and Drug Discovery
Our guest today is Zavain Dar, a partner at Lux Capital and a founding investor in Anagenex. He speaks about his investments in cutting-edge medical tech companies, especially in the drug discovery space. He also describes common pitfalls faced by medical start-ups and gives advice to aspiring entr…
Ep. 11: Zavain Dar, Lux Capital
Zavain breaks down AI, basketball and just is an all around great dude.
Zavain Dar is a Principal with Lux Capital, he focuses on machine learning, crypto currency and everything that requires you to think 20 years out. He has been a mentor with Boost VC for years and is wise beyond his years.
ht…
Parsing Complexity with Zavain Dar
Zavain Dar is a venture capitalist based in New York and San Francisco. He spoke with us about his work that takes him from business and investment in Silicon Valley to science and teaching at Stanford and elsewhere.Full show notes are available at sourcesandmethods.com
Zavain Dar - Creating deep tech for a new era
Zav is one of the most "in" people in tech right now. Holding a Master's in Computer Science from Stanford, Zav is a partner at Lux Capital, which is a VC firm focused on investing in emerging tech from the most innovative sectors. At Lux, Zav's been drawn to companies that use AI and machine learn…
A New Dimension (w/Nan Li, Adam Goulburn, and Zavain Dar)
I was the first to report that Nan Li, Adam Goulburn, and Zavain Dar were setting out to create a venture capital firm back in August 2022. So when the trio finally announced their $350 million life sciences and technology-focused venture firm, called Dimension, I had to have them on the podcast.
…
Babbage: AI: The end of the scientific method?
Researchers are using artificial intelligence techniques to invent medicines and materials—but in the process are they upending the scientific method itself? The AI approach is a form of trial-and-error at scale, or “radical empiricism”. But does AI-driven science uncover new answers that humans ca…
China's AI Push Sounds Alarms, Airplane Seat Debate, Chris Best Joins | Ferdinand Dabitz, Kaiwei Tang, Steven Schwartz, Katie Roof, Zavain Dar, Chad Edwards
(01:58) - China's AI Push Sounds Alarms
(36:37) - Should You Recline Your Airplane Seat?
(42:47) - 𝕏 Timeline Reactions
(51:39) - Ferdinand Dabitz, the 25-year-old CEO of Augustus Bank, discusses the company's recent $180 million Series B funding round, which elevated its valuation to $1 bi…
Zavain Dar on Hugging Face, NVIDIA & Why Silicon Valley Should Pay Attention to China
What does NVIDIA really get from Hugging Face—and what is Silicon Valley missing about China?
Zavain Dar, co-founder of Dimension and an early Hugging Face investor during his time at Lux Capital, joins Eric Newcomer to unpack NVIDIA’s open source strategy, the competition with OpenAI and Anthropic…
เครื่องมือค้นหาพอดแคสต์
คุณสามารถใช้เว็บไซต์ของเราเพื่อค้นหาพอดแคสต์ของ3,834,470และตอนของ197,263,118ตามบุคคล สถานที่ หรือหัวข้อ
If I have seen further than others, it is by listening to podcasts and standing upon the shoulders of
giants.
‐ Isaac "Llamacorn" Newton
